Prevalence and biopsychosocial indicators of fatigue in cancer patients.
biopsychosocial models
fatigue
mental health
neoplasms
psycho‐oncology
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
revised:
29
04
2024
received:
08
01
2024
accepted:
05
05
2024
medline:
31
5
2024
pubmed:
31
5
2024
entrez:
31
5
2024
Statut:
ppublish
Résumé
Symptoms of cancer-related fatigue (CRF) can have a significant impact on patients' quality of life and treatment adherence. We aimed to investigate the relationship between CRF and multiple psychosocial and somatic indicators within a large mixed cancer sample. In this cross-sectional study, N = 1787 outpatients with cancer were assessed for CRF, pain, anxiety, and depression using validated screening instruments. We further obtained clinical parameters (Hb, CRP, creatinine, leukocytes, ASAT, and ALAT), sociodemographic data (age, gender, income, education level, marital status, parenthood, and living area), and lifestyle factors. Multivariate linear regression models were applied to estimate the impact of each indicator on CRF. Overall, 90.6% of patients experienced some CRF, with 14.8% experiencing severe CRF. No gender difference was found in the prevalence of CRF. Patients with higher levels of pain, depressive symptoms, and lower Hb levels had significantly higher levels of CRF (p The present results demonstrate a high prevalence of CRF and highlight that not only somatic and psychosocial factors, but also lifestyle factors prior to diagnosis appear to be associated with the etiology and persistence of CRF. To effectively treat CRF, a biopsychosocial, personalized approach is recommended.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e7293Informations de copyright
© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.
Références
Berger AM, Mooney K, Alvarez‐Perez A, et al. Cancer‐related fatigue, version 2.2015. J Natl Compr Cancer Netw. 2015;13(8):1012‐1039. doi:10.6004/jnccn.2015.0122
Hammer MJ, Cooper B, Paul SM, et al. Identification of distinct symptom profiles in cancer patients using a pre‐specified symptom cluster. J Pain Symptom Manag. 2022;64(1):17‐27. doi:10.1016/j.jpainsymman.2022.03.007
IJsbrandy C, Ottevanger PB, Gerritsen WR, van Harten WH, Hermens RPMG. Determinants of adherence to physical cancer rehabilitation guidelines among cancer patients and cancer centers: a cross‐sectional observational study. J Cancer Surviv. 2021;15(1):163‐177. doi:10.1007/s11764-020-00921-8
Weber D, O'Brien K. Cancer and cancer‐related fatigue and the interrelationships with depression, stress, and inflammation. J Evid Based Complementary Altern Med. 2017;22(3):502‐512. doi:10.1177/2156587216676122
Knefel M, Zeilinger EL, Erfurth A, et al. Affective temperament, fatigue, and pain in cancer patients. J Affect Disord. 2023;340:80‐87. doi:10.1016/j.jad.2023.08.003
Dhruva A, Dodd M, Paul SM, et al. Trajectories of fatigue in patients with breast cancer before, during, and after radiation therapy. Cancer Nurs. 2010;33(3):201‐212. doi:10.1097/NCC.0b013e3181c75f2a
Manitta V, Zordan R, Cole‐Sinclair M, Nandurkar H, Philip J. The symptom burden of patients with hematological malignancy: a cross‐sectional observational study. J Pain Symptom Manag. 2011;42(3):432‐442. doi:10.1016/j.jpainsymman.2010.12.008
Lacourt TE, Kavelaars A, Ohanian M, et al. Patient‐reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia. Oncotarget. 2018;9(58):31244‐31252. doi:10.18632/oncotarget.25787
Al Maqbali M, Al Sinani M, Al Naamani Z, Al Badi K, Tanash MI. Prevalence of fatigue in patients with cancer: a systematic review and meta‐analysis. J Pain Symptom Manag. 2021;61(1):167‐189.e14. doi:10.1016/j.jpainsymman.2020.07.037
Kuhnt S, Friedrich M, Schulte T, Esser P, Hinz T. Predictors of fatigue in cancer patients: a longitudinal study. Support Care Cancer. 2019;27(9):3463‐3471. doi:10.1007/s00520-019-4660-4
Bower JE. The role of neuro‐immune interactions in cancer‐related fatigue: biobehavioral risk factors and mechanisms. Cancer. 2019;125(3):353‐364. doi:10.1002/cncr.31790
Feng LR, Barb JJ, Regan J, Saligan LN. Plasma metabolomic profile associated with fatigue in cancer patients. Cancer Med. 2021;10(5):1623‐1633. doi:10.1002/cam4.3749
Saligan LN, Olson K, Filler K, et al. The biology of cancer‐related fatigue: a review of the literature. Support Care Cancer. 2015;23(8):2461‐2478. doi:10.1007/s00520-015-2763-0
Goklemez S, Saligan LN, Pirsl F, et al. Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft‐versus‐host disease. Bone Marrow Transplant. 2021;56(12):2934‐2939. doi:10.1038/s41409-021-01419-2
Jhamb M, Abdel‐Kader K, Yabes J, et al. Comparison of fatigue, pain, and depression in patients with advanced kidney disease and cancer ‐ symptom burden and clusters. J Pain Symptom Manag. 2019;57(3):566‐575.e3. doi:10.1016/j.jpainsymman.2018.12.006
McCall MK, Connolly M, Nugent B, Conley YP, Bender CM, Rosenzweig MQ. Symptom experience, management, and outcomes according to race and social determinants including genomics, epigenomics, and metabolomics (SEMOARS + GEM): an explanatory model for breast cancer treatment disparity. J Cancer Educ. 2020;35(3):428‐440. doi:10.1007/s13187-019-01571-w
Dhruva A, Aouizerat BE, Cooper B, et al. Cytokine gene associations with self‐report ratings of morning and evening fatigue in oncology patients and their family caregivers. Biol Res Nurs. 2015;17(2):175‐184. doi:10.1177/1099800414534313
Wright F, D'Eramo Melkus G, Hammer M, et al. Predictors and trajectories of morning fatigue are distinct from evening fatigue. J Pain Symptom Manag. 2015;50(2):176‐189. doi:10.1016/j.jpainsymman.2015.02.016
Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev. 2009;2009(1):CD006953. doi:10.1002/14651858.CD006953.pub2
Cedenilla Ramón N, Calvo Arenillas JI, Aranda Valero S, Sánchez Guzmán A, Moruno MP. Psychosocial interventions for the treatment of cancer‐related fatigue: an umbrella review. Curr Oncol. 2023;30(3):2954‐2977. doi:10.3390/curroncol30030226
Belloni S, Arrigoni C, Caruso R. Effects from physical exercise on reduced cancer‐related fatigue: a systematic review of systematic reviews and meta‐analysis. Acta Oncol. 2021;60(12):1678‐1687. doi:10.1080/0284186X.2021.1962543
Bower JE, Wiley J, Petersen L, Irwin MR, Cole SW, Ganz PA. Fatigue after breast cancer treatment: biobehavioral predictors of fatigue trajectories. Health Psychol. 2018;37:1025‐1034. doi:10.1037/hea0000652
Jakovljevic K, Kober KM, Block A, et al. Higher levels of stress are associated with a significant symptom burden in oncology outpatients receiving chemotherapy. J Pain Symptom Manag. 2021;61(1):24‐31.e4. doi:10.1016/j.jpainsymman.2020.07.019
Bower JE, Ganz PA, Irwin MR, et al. Do all patients with cancer experience fatigue? A longitudinal study of fatigue trajectories in women with breast cancer. Cancer. 2021;127(8):1334‐1344. doi:10.1002/cncr.33327
Unseld M, Zeilinger EL, Fellinger M, et al. Prevalence of pain and its association with symptoms of post‐traumatic stress disorder, depression, anxiety and distress in 846 cancer patients: a cross sectional study. Psycho‐Oncol. 2021;30(4):504‐510. doi:10.1002/pon.5595
Hajj A, Chamoun R, Salameh P, et al. Fatigue in breast cancer patients on chemotherapy: a cross‐sectional study exploring clinical, biological, and genetic factors. BMC Cancer. 2022;22(1):16. doi:10.1186/s12885-021-09072-0
Mao H, Bao T, Shen X, et al. Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors. Eur J Cancer. 2018;101:47‐54. doi:10.1016/j.ejca.2018.06.009
Huang HP, Chen ML, Liang J, Miaskowski C. Changes in and predictors of severity of fatigue in women with breast cancer: a longitudinal study. Int J Nurs Stud. 2014;51(4):582‐592. doi:10.1016/j.ijnurstu.2013.09.003
Wright F, D'Eramo Melkus G, Hammer M, et al. Trajectories of evening fatigue in oncology outpatients receiving chemotherapy. J Pain Symptom Manag. 2015;50(2):163‐175. doi:10.1016/j.jpainsymman.2015.02.015
Cramer H, Lauche R, Klose P, Lange S, Langhorst J, Dobos GJ. Yoga for improving health‐related quality of life, mental health and cancer‐related symptoms in women diagnosed with breast cancer. Cochrane Database Syst Rev. 2017;1:CD010802. doi:10.1002/14651858.CD010802.pub2
Temel JS, Pirl WF, Recklitis CJ, Cashavelly B, Lynch TJ. Feasibility and validity of a one‐item fatigue screen in a thoracic oncology clinic. J Thorac Oncol. 2006;1(5):454‐459. doi:10.1016/S1556-0864(15)31611-7
Breivik H, Borchgrevink PC, Allen SM, et al. Assessment of pain. Br J Anaesth. 2008;101(1):17‐24. doi:10.1093/bja/aen103
Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29. doi:10.1186/1477-7525-1-29
Zeilinger EL, Nader IW, Wiedermann W, et al. Latent structure and measurement invariance of the hospital anxiety and depression scale in cancer outpatients. Int J Clin Health Psychol. 2022;22(3):100315. doi:10.1016/j.ijchp.2022.100315
Hammouri HM, Sabo RT, Alsaadawi R, Kheirallah KA. Handling skewed data: a comparison of two popular methods. Appl Sci. 2020;10(18):6247. doi:10.3390/app10186247
Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Lawrence Erlbaum Associates; 1988.
Gignac GE, Szodorai ET. Effect size guidelines for individual differences researchers. Personal Individ Differ. 2016;102:74‐78. doi:10.1016/j.paid.2016.06.069
Zeilinger EL, Gaiger A. Data from: fatigue in cancer outpatients. OSF. 2022. doi:10.17605/OSF.IO/YHF98
Musarezaie A, Khaledi F, Esfahani HN, Ghaleghasemi TM. Factors affecting quality of life and fatigue in patients with leukemia under chemotherapy. J Educ Health Promot. 2014;3(64):74‐79.
Shin J, Harris C, Oppegaard K, et al. Worst pain severity Profiles of oncology patients are associated with significant stress and multiple co‐occurring symptoms. J Pain. 2022;23(1):74‐88. doi:10.1016/j.jpain.2021.07.001
Bekes I, Eichler M, Singer S, et al. Impact of granulocyte colony‐stimulating factor (G‐CSF) and epoetin (EPO) on hematologic toxicities and quality of life in patients during adjuvant chemotherapy in early breast cancer: results from the multi‐center randomized ADEBAR trial. Clin Breast Cancer. 2020;20(6):439‐447. doi:10.1016/j.clbc.2020.03.008
Zeilinger EL, Oppenauer C, Knefel M, et al. Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross‐sectional study. Epidemiol Psychiatr Sci. 2022;31:e74. doi:10.1017/S2045796022000592
Gaiger A, Lubowitzki S, Krammer K, et al. The cancer survival index—a prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies. Cancer Med. 2022;11(18):3387‐3396. doi:10.1002/cam4.4697
Knefel M, Zeilinger EL, Lubowitzki S, et al. Risk as a pattern over time: delineation of time‐dependent risk factors in biological, psychological, and social variables in cancer patients. Cancer. 2023;129(21):3466‐3475. doi:10.1002/cncr.34953
Andrykowski MA, Donovan KA, Jacobsen PB. Magnitude and correlates of response shift in fatigue ratings in women undergoing adjuvant therapy for breast cancer. J Pain Symptom Manag. 2009;37(3):341‐351. doi:10.1016/j.jpainsymman.2008.03.015
Raghupathi V, Raghupathi W. The influence of education on health: an empirical assessment of OECD countries for the period 1995–2015. Arch Public Health. 2020;78(1):20. doi:10.1186/s13690-020-00402-5
Zeilinger EL, Knefel M, Schneckenreiter C, et al. The impact of COVID‐19 and socioeconomic status on psychological distress in cancer patients. Int J Clin Health Psychol. 2023;23(4):100404. doi:10.1016/j.ijchp.2023.100404
Zeilinger EL, Lubowitzki S, Unseld M, et al. The impact of COVID‐19 on cancer care of outpatients with low socioeconomic status. Int J Cancer. 2022;17:77‐82. doi:10.1002/ijc.33960
Akechi T, Kugaya A, Okamura H, Yamawaki S, Uchitomi Y. Fatigue and its associated factors in ambulatory cancer patients. J Pain Symptom Manag. 1999;17(1):42‐48. doi:10.1016/S0885-3924(98)00105-5
Schieman S, Glavin P. Education and work‐family Conflict: explanations, contingencies and mental health consequences. Soc Forces. 2011;89(4):1341‐1362. doi:10.1093/sf/89.4.1341
Deaton A, Stone AA. Evaluative and hedonic wellbeing among those with and without children at home. Proc Natl Acad Sci USA. 2014;111(4):1328‐1333. doi:10.1073/pnas.1311600111
Yabroff KR, Bradley C, Shih YCT. Understanding financial hardship among cancer survivors in the United States: strategies for prevention and mitigation. J Clin Oncol. 2020;38(4):292‐301. doi:10.1200/JCO.19.01564
Han X, Zhao J, Zheng Z, De Moor JS, Virgo KS, Yabroff KR. Medical financial hardship intensity and financial sacrifice associated with cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2020;29(2):308‐317. doi:10.1158/1055-9965.EPI-19-0460
Richard P. The burden of medical debt faced by households with dependent children in the United States: implications for the affordable care act of 2010. J Fam Econ Iss. 2016;37(2):212‐225. doi:10.1007/s10834-016-9491-6
Aggarwal A, Ginsburg O, Fojo T. Cancer economics, policy and politics: what informs the debate? Perspectives from the EU, Canada and US. J Cancer Policy. 2014;2(1):1‐11. doi:10.1016/j.jcpo.2014.02.002
Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high‐income countries. Lancet Oncol. 2011;12(10):933‐980. doi:10.1016/S1470-2045(11)70141-3
Wang Y, Tian L, Liu X, et al. Multidimensional predictors of cancer‐related fatigue based on the predisposing, precipitating, and perpetuating (3P) model: a systematic review. Cancer. 2023;15(24):5879. doi:10.3390/cancers15245879
Kang YE, Yoon JH, Park NH, Ahn YC, Lee EJ, Son CG. Prevalence of cancer‐related fatigue based on severity: a systematic review and meta‐analysis. Sci Rep 2023;13(1): 12815. doi:10.1038/s41598-023-39046-0
Koch M, Hjermstad MJ, Tomaszewski K, et al. Gender effects on quality of life and symptom burden in patients with lung cancer: results from a prospective, cross‐cultural, multi‐center study. J Thorac Dis. 2020;12(8):4253‐4261. doi:10.21037/jtd-20-1054
Oertelt‐Prigione S, de Rooij BH, Mols F, et al. Sex‐differences in symptoms and functioning in >5000 cancer survivors: results from the PROFILES registry. Eur J Cancer. 2021;156:24‐34. doi:10.1016/j.ejca.2021.07.019
Miaskowski C. Gender differences in pain, fatigue, and depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:139‐143. doi:10.1093/jncimonographs/lgh024
Fleer J, Sleijfer DT, Hoekstra HJ, Tuinman MA, Hoekstra‐Weebers JEHM. Prevalence, changes in and correlates of fatigue in the first year after diagnosis of testicular cancer. Anticancer Res. 2005;25(6C):4647‐4653.
Butt Z, Rao AV, Lai JS, Abernethy AP, Rosenbloom SK, Cella D. Age‐associated differences in fatigue among patients with cancer. J Pain Symptom Manag. 2010;40(2):217‐223. doi:10.1016/j.jpainsymman.2009.12.016
World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2011 https://apps.who.int/iris/handle/10665/85839